Will This Cinema Stock Be a Blockbuster for Investors?

Canadians seeking a high-tech growth stock may need not go any further than their local theatre.

| More on:
The Motley Fool
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

IMAX Corporation (TSX: IMX)(NYSE: IMAX), a leader in big screen entertainment, offers a unique, “immersive” cinematic experience by combining proprietary software, theater architecture, and equipment. Its network of screens is becoming an increasingly important distribution platform for major Hollywood films around the globe.

Shares of IMAX are flat year to date, versus a 6% gain in the S&P/TSX Composite Index (TSX: ^OSPTX). But in 2013, IMAX shares gained over 40%, handily beating the broader Canadian market.

Here are two reasons why IMAX could be a potential blockbuster for investors.

Strong lineup

A strong lineup of prospective box office hits over the next two years holds great promise for IMAX.

Just last month, IMAX announced an agreement with a division of The Walt Disney Company (NYSE: DIS) to release several of its upcoming films in IMAX theaters. Many of Disney’s most highly anticipated, live-action films will find themselves on IMAX’s screens, including Marvel’s Captain America: The Winter Soldier, Maleficent, Marvel’s Guardians of the Galaxy, Marvel’s Avengers: Age of Ultron, Tomorrowland, and the highly anticipated Star Wars: Episode VII.

This announcement comes on the heels of tremendous success enjoyed by the movie Gravity, only the third film in history to earn $100 million worldwide in IMAX theaters alone.

International expansion

At the end of last year, IMAX had 837 theater systems in operation: 720 commercial and 117 in institutions, like museums and science centres. This represents growth of nearly 15% over 2012. In 2013, the company signed a total of 277 theater commitments, roughly double the number in 2012, and a company record. IMAX’s current backlog of 407 theaters is also a company record.

A significant portion of the company’s recent growth comes from international markets, a trend that is expected to continue. In 2013, nearly 84% of the company’s new theater agreements were for international markets, including China, India, Latin America, and Eastern and Western Europe.

Interestingly, 2013 marked a turning point for IMAX – the first year international markets surpassed Canada and the U.S. in terms of revenue. China continues to be the company’s fastest-growing market. At the end of 2013, the company had 173 theaters operating in China, with an additional 239 theaters in backlog, all scheduled for installation over the next seven years.

Foolish bottom line

International expansion and a strong lineup of blockbuster releases are promising indicators for future revenue and profit growth at IMAX. But its still too early to tell how this movie will end.

The stock is expensive, with a forward price-to-earnings ratio of 28.6, representing an 8% premium to its five-year average and a 19% premium to the S&P/TSX Composite Index. And its expansion in China poses risks. In addition to the challenges IMAX may face enforcing its intellectual property rights, the Chinese government regulates the number and timing of Hollywood films released in the country.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Justin K Lacey has no positions in any of the stocks mentioned in this article. Motley Fool Co-founder David Gardner owns shares of Walt Disney. The Motley Fool owns shares of Imax and Walt Disney.

More on Investing

Workers use a microscope to do medical research in a modern laboratory.
Investing

Is Now the Time to Buy Health Care Stocks?

Health care stocks are on the up, but does that mean you should go ahead and buy anything? In short:…

Read more »

Volatile market, stock volatility
Investing

2 Volatile Stocks to Hold for a Decade

The market is full of opportunities for investors. But does that opportunity include some volatile stocks to hold?

Read more »

Arrowings ascending on a chalkboard
Investing

1 Under-the-Radar U.S. Stock to Buy in August

Canadians on the hunt for an undervalued and under-the-radar U.S. stock should consider Match Group Inc.

Read more »

Woman has an idea
Dividend Stocks

2 Low-Risk Growth Stocks Paying Great Dividends

These top TSX dividend stocks give investors exposure to interesting growth opportunities.

Read more »

A person builds a rock tower on a beach.
Dividend Stocks

Got $300? 2 Simple TSX Stocks to Buy Right Now

These two simple TSX stocks have everything a long-term investor looking to dollar cost average into a position wants right…

Read more »

A golden egg in a nest
Dividend Stocks

Millennials: No Excuses! Start Saving for Retirement Right Now.

Millennials, we need to stop complaining and start bragging. We're great savers, so it's time to start investing in TSX…

Read more »

Value for money
Dividend Stocks

3 UNDERVALUED TSX Stocks to Buy in August

Here are some attractively valued TSX stocks for the long term.

Read more »

A young man throwing and catching his daughter above his head
Dividend Stocks

Parents: Double Your CCB Payments This Month!

Parents can use those CCB payments to their benefit and double them this year month after month -- no waiting,…

Read more »